Scinai Immunotherapeutics (SCNI) Return on Capital Employed [ROCE] (2019 - 2026)
Scinai Immunotherapeutics (SCNI) posted Return on Capital Employed [ROCE] of -55.29% for Q2 2026, up 15.95 percentage points from the prior quarter.
Powered by 
Analysis
Scinai Immunotherapeutics (SCNI) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends
For FY2025, Scinai Immunotherapeutics' Return on Capital Employed [ROCE] came in at -88.98%, down 25.72 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has declined for six consecutive years, with a five-year change of -219.20 percentage points (FY2020 to FY2025).
- In prior years, Scinai Immunotherapeutics' Return on Capital Employed [ROCE] was -63.26% in FY2024 (-15.89 pp), -47.37% in FY2023 (-88.02 pp), 40.65% in FY2022 (-7.79 pp) and 48.44% in FY2021 (-81.78 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.26 Bn | 1,100.85 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 634.57 Bn | 554.43 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 505.88 Bn | 478.99 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 291.59 Bn | 255.58 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 265.00 Bn | 238.69 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 238.10 Bn | 193.50 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 195.13 Bn | 169.32 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn | 11.86% |
| 10 | Scinai Immunotherapeutics | 130,775.81 | -8.14 Mn | -1.25 Mn | -55.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -55.29% |
| Mar 31, 2026 | -71.24% |
| Dec 31, 2024 | -78.18% |
| Sep 30, 2024 | -67.40% |
| Jun 30, 2024 | -55.19% |
| Mar 31, 2024 | -29.94% |
| Dec 31, 2023 | -59.74% |
| Sep 30, 2023 | -152.43% |
| Jun 30, 2023 | -115.29% |
| Mar 31, 2023 | -103.48% |
| Dec 31, 2022 | -104.96% |
| Sep 30, 2022 | 43.71% |
| Dec 31, 2021 | -23.34% |
| Sep 30, 2021 | -66.65% |
| Sep 30, 2020 | -20.58% |
| Jun 30, 2020 | -94.73% |
| Dec 31, 2019 | -76.98% |
| Sep 30, 2019 | -77.37% |
| Jun 30, 2019 | -86.95% |
API Access
Scinai Immunotherapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SCNI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "SCNI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SCNI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();